JP2024170583A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024170583A5 JP2024170583A5 JP2024154560A JP2024154560A JP2024170583A5 JP 2024170583 A5 JP2024170583 A5 JP 2024170583A5 JP 2024154560 A JP2024154560 A JP 2024154560A JP 2024154560 A JP2024154560 A JP 2024154560A JP 2024170583 A5 JP2024170583 A5 JP 2024170583A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- excipient
- nanoparticles
- composition according
- therapeutic agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 23
- 239000000546 pharmaceutical excipient Substances 0.000 claims 9
- 239000003814 drug Substances 0.000 claims 6
- 239000002105 nanoparticle Substances 0.000 claims 6
- 229940124597 therapeutic agent Drugs 0.000 claims 6
- 150000001413 amino acids Chemical class 0.000 claims 5
- 150000005846 sugar alcohols Chemical class 0.000 claims 5
- BCEHBSKCWLPMDN-MGPLVRAMSA-N voriconazole Chemical compound C1([C@H](C)[C@](O)(CN2N=CN=C2)C=2C(=CC(F)=CC=2)F)=NC=NC=C1F BCEHBSKCWLPMDN-MGPLVRAMSA-N 0.000 claims 5
- 229960004740 voriconazole Drugs 0.000 claims 5
- 208000015181 infectious disease Diseases 0.000 claims 3
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims 2
- 229930195725 Mannitol Natural products 0.000 claims 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical group C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 2
- 229940121375 antifungal agent Drugs 0.000 claims 2
- 239000003429 antifungal agent Substances 0.000 claims 2
- 235000010355 mannitol Nutrition 0.000 claims 2
- 239000000594 mannitol Substances 0.000 claims 2
- 208000035473 Communicable disease Diseases 0.000 claims 1
- 241000233866 Fungi Species 0.000 claims 1
- 210000004072 lung Anatomy 0.000 claims 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862702674P | 2018-07-24 | 2018-07-24 | |
| US62/702,674 | 2018-07-24 | ||
| JP2021503813A JP7611813B2 (ja) | 2018-07-24 | 2019-07-24 | 超高速凍結による表面改質された治療活性粒子の組成物 |
| PCT/US2019/043202 WO2020023614A1 (en) | 2018-07-24 | 2019-07-24 | Compositions of surface-modified therapeutically active particles by ultra-rapid freezing |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503813A Division JP7611813B2 (ja) | 2018-07-24 | 2019-07-24 | 超高速凍結による表面改質された治療活性粒子の組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024170583A JP2024170583A (ja) | 2024-12-10 |
| JP2024170583A5 true JP2024170583A5 (https=) | 2025-04-03 |
Family
ID=69181152
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503813A Active JP7611813B2 (ja) | 2018-07-24 | 2019-07-24 | 超高速凍結による表面改質された治療活性粒子の組成物 |
| JP2024154560A Pending JP2024170583A (ja) | 2018-07-24 | 2024-09-09 | 超高速凍結による表面改質された治療活性粒子の組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021503813A Active JP7611813B2 (ja) | 2018-07-24 | 2019-07-24 | 超高速凍結による表面改質された治療活性粒子の組成物 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210338671A1 (https=) |
| EP (1) | EP3827260A4 (https=) |
| JP (2) | JP7611813B2 (https=) |
| KR (1) | KR20210038583A (https=) |
| CN (1) | CN112673257B (https=) |
| AU (1) | AU2019311086A1 (https=) |
| BR (1) | BR112021001290A2 (https=) |
| CA (1) | CA3106618A1 (https=) |
| EA (1) | EA202190331A1 (https=) |
| IL (1) | IL280342A (https=) |
| MX (1) | MX2021000796A (https=) |
| WO (1) | WO2020023614A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2014186754A2 (en) | 2013-05-16 | 2014-11-20 | Board Of Regents The University Of Texas System | Dry solid aluminum adjuvant-containing vaccines and related methods thereof |
| US11918646B2 (en) | 2017-12-11 | 2024-03-05 | Board Of Regents, The University Of Texas System | Dry adjuvanted immune stimulating compositions and use thereof for mucosal administration |
| CN113398079B (zh) * | 2020-03-16 | 2024-01-19 | 鲁南制药集团股份有限公司 | 一种注射用氟达拉滨冻干粉 |
| BR112023001929A2 (pt) | 2020-09-03 | 2023-03-14 | Philip Morris Products Sa | Composições em pó ativas de baixa higroscopicidade |
| US20230301919A1 (en) * | 2020-09-03 | 2023-09-28 | Philip Morris Products S.A. | Freeze dried low hygroscopicity active powder compositions |
| US11793808B2 (en) | 2021-02-22 | 2023-10-24 | Mannkind Corp. | Compositions of clofazimine, combinations comprising them, processes for their preparation, uses and methods comprising them |
| CN117241786A (zh) * | 2021-03-12 | 2023-12-15 | 德克萨斯大学系统董事会 | 使用基于悬浮液的薄膜冷冻制备干燥粉末的方法 |
| US12015755B2 (en) | 2021-03-25 | 2024-06-18 | Korea Advanced Institute Of Science And Technology | Real-time omnidirectional stereo matching method using multi-view fisheye lenses and system thereof |
| CN113484469B (zh) * | 2021-06-30 | 2022-11-18 | 中国科学院青海盐湖研究所 | 水合盐体系相变储能材料纳米尺度相分离的原位表征方法 |
| CN116440084A (zh) * | 2022-01-07 | 2023-07-18 | 浙江萃泽医药科技有限公司 | 一种可吸入的药物粉末制剂及其制备方法 |
| AU2023366929A1 (en) | 2022-10-25 | 2025-05-08 | Veradermics, Incorporated | Compositions and methods of use for modified release minoxidil |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08310969A (ja) * | 1995-05-22 | 1996-11-26 | Lion Corp | 固形薬品組成物及びその製造方法 |
| US7521068B2 (en) * | 1998-11-12 | 2009-04-21 | Elan Pharma International Ltd. | Dry powder aerosols of nanoparticulate drugs |
| CN1750811A (zh) * | 2001-10-19 | 2006-03-22 | 巴克斯特国际公司 | 在冷冻水基质中包括颗粒的稳定组合物 |
| GB0321607D0 (en) * | 2003-09-15 | 2003-10-15 | Vectura Ltd | Manufacture of pharmaceutical compositions |
| US9061027B2 (en) * | 2004-08-27 | 2015-06-23 | Board Of Regents, The University Of Texas System | Enhanced delivery of drug compositions to treat life threatening infections |
| WO2007011396A2 (en) * | 2004-10-29 | 2007-01-25 | President And Fellows Of Harvard College | Particles for treatment of pulmonary infection |
| US8361439B1 (en) * | 2005-01-04 | 2013-01-29 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
| WO2007053923A2 (en) * | 2005-11-11 | 2007-05-18 | Biolab Sanus Farmacêutica Ltda. | Solid pharmaceutical composition comprising agglomerate nanoparticles and a process for producing the same |
| WO2011046842A1 (en) * | 2009-10-12 | 2011-04-21 | The Regents Of The University Of California | Targeted nanoclusters and methods of their use |
| US10973763B2 (en) * | 2011-06-17 | 2021-04-13 | Berg Llc | Inhalable pharmaceutical compositions |
| US9801855B2 (en) * | 2012-03-07 | 2017-10-31 | National Institute Of Pharmaceutical Education And Research (Niper) | Nanocrystalline solid dispersion compositions and process of preparation thereof |
| JP6940416B2 (ja) * | 2015-05-01 | 2021-09-29 | ボード オブ リージェンツ, ザ ユニバーシティ オブ テキサス システムBoard Of Regents, The University Of Texas System | 多剤脆性マトリックス組成物 |
-
2019
- 2019-07-24 JP JP2021503813A patent/JP7611813B2/ja active Active
- 2019-07-24 AU AU2019311086A patent/AU2019311086A1/en active Pending
- 2019-07-24 CN CN201980055623.XA patent/CN112673257B/zh active Active
- 2019-07-24 CA CA3106618A patent/CA3106618A1/en active Pending
- 2019-07-24 US US17/262,313 patent/US20210338671A1/en active Pending
- 2019-07-24 EA EA202190331A patent/EA202190331A1/ru unknown
- 2019-07-24 WO PCT/US2019/043202 patent/WO2020023614A1/en not_active Ceased
- 2019-07-24 MX MX2021000796A patent/MX2021000796A/es unknown
- 2019-07-24 KR KR1020217005060A patent/KR20210038583A/ko not_active Ceased
- 2019-07-24 BR BR112021001290-7A patent/BR112021001290A2/pt unknown
- 2019-07-24 EP EP19840589.6A patent/EP3827260A4/en active Pending
-
2021
- 2021-01-21 IL IL280342A patent/IL280342A/en unknown
-
2024
- 2024-09-09 JP JP2024154560A patent/JP2024170583A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024170583A5 (https=) | ||
| JP2023002662A5 (https=) | ||
| JP2014518268A5 (https=) | ||
| JP2774379B2 (ja) | 医薬エアロゾール組成物ならびにそれらのウイルス疾患の治療および予防用途 | |
| CN111228275A (zh) | 一种化合物在制备治疗病毒性肺炎药物中的应用 | |
| JP2009521473A5 (https=) | ||
| AU2016287580A1 (en) | Compositions and methods for the treatment of viral infection | |
| JP2007511539A5 (https=) | ||
| WO2001001978A1 (fr) | Compositions de medicaments servant a prevenir ou a traiter la myocardite virale | |
| WO2015027848A1 (zh) | 含有帕拉米韦和/或其衍生物制剂的给药方法 | |
| WO2022199049A1 (zh) | 乌司他丁在制备治疗新型冠状病毒肺炎药物中的用途 | |
| WO2019161761A1 (zh) | 一种治疗疟疾的药物组合物 | |
| FI4199922T3 (fi) | (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa | |
| US11497747B2 (en) | Compositions and methods for treating lung injuries associated with SARS-CoV-2 infections | |
| JPWO2022096708A5 (https=) | ||
| CN102670684B (zh) | 白薇总皂苷的应用 | |
| CN115867288A (zh) | 用于治疗呼吸系统病症的组合物 | |
| JPWO2020240472A5 (https=) | ||
| JPWO2023107938A5 (https=) | ||
| CN110841069A (zh) | 一种含有沙利度胺与抗真菌药物的药物组合物及应用 | |
| RU2772701C1 (ru) | Способы лечения инфекционных заболеваний, вызванных коронавирусом | |
| US12171732B2 (en) | Compositions and use of N-chlorotaurine for treatment and prevention of respiratory infections | |
| JPH10175852A5 (https=) | ||
| EP3906934B1 (en) | Application of dalargin for the prevention of viral respiratory infections and prevention of the development of complications during viral respiratory infections | |
| RU2747890C1 (ru) | Средство для снижения риска и облегчения симптомов заражения бета-коронавирусной инфекцией |